Literature DB >> 20574002

Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Iekuni Oh1, Katsutoshi Ozaki, Akiko Meguro, Keiko Hatanaka, Masanori Kadowaki, Haruko Matsu, Raine Tatara, Kazuya Sato, Yoichiro Iwakura, Susumu Nakae, Katsuko Sudo, Takanori Teshima, Warren J Leonard, Keiya Ozawa.   

Abstract

We previously showed that transplantation with IL-21R gene-deficient splenocytes resulted in less severe graft-versus-host disease (GVHD) than was observed with wild type splenocytes. In this study, we sought to find mechanism(s) explaining this observation. Recipients of donor CD4(+) T cells lacking IL-21R exhibited diminished GVHD symptoms, with reduced inflammatory cell infiltration into the liver and intestine, leading to prolonged survival. After transplantation, CD4(+) T cell numbers in the spleen were reduced, and MLR and cytokine production by CD4(+) T cells were impaired. These results suggest that IL-21 might promote GVHD through enhanced production of effector CD4(+) T cells. Moreover, we found that CD25 depletion altered neither the impaired MLR in vitro nor the ameliorated GVHD symptoms in vivo. Thus, the attenuated GVHD might be caused by an impairment of effector T cell differentiation itself, rather than by an increase in regulatory T cells and suppression of effector T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574002      PMCID: PMC3052859          DOI: 10.4049/jimmunol.0902217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

Authors:  B Nikolic; S Lee; R T Bronson; M J Grusby; M Sykes
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

Authors:  Cornelius Schmaltz; Onder Alpdogan; Stephanie J Muriglan; Barry J Kappel; Jimmy A Rotolo; Eric T Ricchetti; Andrew S Greenberg; Lucy M Willis; George F Murphy; James M Crawford; Marcel R M van den Brink
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

3.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.

Authors:  J Parrish-Novak; S R Dillon; A Nelson; A Hammond; C Sprecher; J A Gross; J Johnston; K Madden; W Xu; J West; S Schrader; S Burkhead; M Heipel; C Brandt; J L Kuijper; J Kramer; D Conklin; S R Presnell; J Berry; F Shiota; S Bort; K Hambly; S Mudri; C Clegg; M Moore; F J Grant; C Lofton-Day; T Gilbert; F Rayond; A Ching; L Yao; D Smith; P Webster; T Whitmore; M Maurer; K Kaushansky; R D Holly; D Foster
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

4.  Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

Authors:  Cecile King; Alex Ilic; Kersten Koelsch; Nora Sarvetnick
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

5.  IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response.

Authors:  Mari Strengell; Timo Sareneva; Don Foster; Ilkka Julkunen; Sampsa Matikainen
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

6.  IL-21 is critical for GVHD in a mouse model.

Authors:  A Meguro; K Ozaki; I Oh; K Hatanaka; H Matsu; R Tatara; K Sato; W J Leonard; K Ozawa
Journal:  Bone Marrow Transplant       Date:  2009-08-31       Impact factor: 5.483

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

8.  Interleukin-21 inhibits dendritic cell activation and maturation.

Authors:  Katja Brandt; Silvia Bulfone-Paus; Donald C Foster; René Rückert
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

9.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Authors:  Susumu Nakae; Yutaka Komiyama; Aya Nambu; Katsuko Sudo; Michiko Iwase; Ikuo Homma; Kenji Sekikawa; Masahide Asano; Yoichiro Iwakura
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

10.  Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells.

Authors:  Andrea L Wurster; Vikki L Rodgers; Abhay R Satoskar; Matthew J Whitters; Deborah A Young; Mary Collins; Michael J Grusby
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more
  8 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Authors:  Alan M Hanash; Lucy W Kappel; Nury L Yim; Rebecca A Nejat; Gabrielle L Goldberg; Odette M Smith; Uttam K Rao; Lindsay Dykstra; Il-Kang Na; Amanda M Holland; Jarrod A Dudakov; Chen Liu; George F Murphy; Warren J Leonard; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

3.  Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.

Authors:  A Meguro; K Ozaki; K Hatanaka; I Oh; K Sudo; T Ohmori; H Matsu; R Tatara; K Sato; Y Sakata; S Nakae; W J Leonard; K Ozawa
Journal:  Bone Marrow Transplant       Date:  2011-01-24       Impact factor: 5.483

Review 4.  Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Authors:  F Malard; B Gaugler; B Lamarthee; M Mohty
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

5.  Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.

Authors:  Helen M McGuire; Stacey Walters; Alexis Vogelzang; Carol M Y Lee; Kylie E Webster; Jonathan Sprent; Daniel Christ; Shane Grey; Cecile King
Journal:  Diabetes       Date:  2011-03       Impact factor: 9.461

6.  IL2-IL21 gene cluster polymorphism is not associated with allograft function after kidney transplantation.

Authors:  Ewa Kwiatkowska; Leszek Domanski; Karolina Kłoda; Andrzej Pawlik; Krzysztof Safranow; Kazimierz Ciechanowski
Journal:  Int Urol Nephrol       Date:  2014-11-08       Impact factor: 2.370

7.  Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.

Authors:  Aurélie Tormo; Fatemeh Khodayarian; Yun Cui; Edouard Al-Chami; Reem Kanjarawi; Beatriz Noé; Huijie Wang; Moutih Rafei
Journal:  J Hematol Oncol       Date:  2017-06-14       Impact factor: 17.388

Review 8.  Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease.

Authors:  Clint Piper; William R Drobyski
Journal:  Front Immunol       Date:  2019-02-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.